NCT03519971 2025-10-28Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung CancerAstraZenecaPhase 3 Active not recruiting328 enrolled 23 charts
NCT04807166 2024-07-03Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian CancerThe First Affiliated Hospital with Nanjing Medical UniversityPhase 2 Active not recruiting56 enrolled